Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis highlights SPP1.

Mounts K, Liu YD, Fujita M, Oyegunle J, Neziraj T, Pollak SV, Nandakumar R, Ngouth N, Steele SU, Cortese I, et al.